BoMRA Public-Pharmacovigilance and Post-Market Surveillance Stakeholder Engagement

The Department of Pharmacovigilance and Clinical Trials will hold a one-day, hybrid stakeholder engagement session to discuss pharmacovigilance guidelines for Marketing Authorisation Holders (MAHs), as